XML 30 R17.htm IDEA: XBRL DOCUMENT v3.8.0.1
FINANCIAL INSTRUMENTS (Notes)
3 Months Ended
Mar. 31, 2018
Fair Value Disclosures [Abstract]  
FINANCIAL INSTRUMENTS FINANCIAL INSTRUMENTS

Fair Value Measurements

Authoritative guidance associated with fair value measurements provides a framework for measuring fair value and establishes a fair value hierarchy that prioritizes the inputs used to measure fair value, giving the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 inputs), then significant other observable inputs (Level 2 inputs) and the lowest priority to significant unobservable inputs (Level 3 inputs). The following methods and assumptions were used to estimate the fair value of each class of financial instruments:

For marketable securities, the carrying value of these amounts is a reasonable estimate of their fair value.
Fair values for long-term debt and project debt are determined using quoted market prices (Level 1).
The fair value of our interest rate swaps are determined by applying the Euribor forward curve observable in the market to the contractual terms of our floating to fixed rate swap agreements. The fair value of the interest rate swaps is adjusted to reflect counterparty risk of non-performance, and is based on the counterparty’s credit spread in the credit derivatives market.
The fair values of our energy hedges were determined using the spread between our fixed price and the forward curve information available within the market.

The estimated fair value amounts have been determined using available market information and appropriate valuation methodologies. However, considerable judgment is required in interpreting market data to develop estimates of fair value. Accordingly, the estimates presented herein are not necessarily indicative of the amounts that we would realize in a current market exchange and are based on pertinent information available to us as of March 31, 2018. Such amounts have not been comprehensively revalued for purposes of these financial statements and current estimates of fair value may differ significantly from the amounts presented herein.

The following table presents information about the fair value measurement of our assets and liabilities as of March 31, 2018 and December 31, 2017:
Financial Instruments Recorded at Fair Value on a Recurring Basis:
 
Fair Value Measurement Level
 
March 31, 2018

December 31, 2017
 
 
 
 
(In millions)
Assets:
 
 
 
 
 
 
Investments — mutual and bond funds (1)
 
1
 
2

 
2

Total assets:
 
 
 
$
2

 
$
2

Liabilities:
 
 
 
 
 
 
Derivative liability — energy hedges (2)
 
2
 
$

 
$
5

Derivative liability — interest rate swaps included in liabilities held for sale
 
2
 

 
7

Total liabilities:
 
 
 
$

 
$
12

(1)
Included in other noncurrent assets in the condensed consolidated balance sheets.
(2)
The short-term balance is included in "accrued expenses and other current liabilities" and the long-term balance is included in "other liabilities" in the condensed consolidated balance sheets.

The following financial instruments are recorded at their carrying amount (in millions):
 
 
As of March 31, 2018
 
As of December 31, 2017
Financial Instruments Recorded at
     Carrying Amount:
 
Carrying
Amount
 
Estimated
Fair Value
 
Carrying
Amount
 
Estimated
Fair Value
Liabilities:
 
 
 
 
 
 
 
 
Long-term debt 
 
$
2,289

 
$
2,284

 
$
2,349

 
$
2,371

Project debt
 
$
165

 
$
168

 
$
174

 
$
179

Project debt included in liabilities held for sale
 
$

 
$

 
$
510

 
$
510



We are required to disclose the fair value of financial instruments for which it is practicable to estimate that value. The fair value of short-term financial instruments such as cash and cash equivalents, restricted cash, accounts receivables, prepaid expenses and other assets, accounts payable and accrued expenses approximates their carrying value on the condensed consolidated balance sheets due to their short-term nature.

In addition to the recurring fair value measurements, certain assets are measured at fair value on a non-recurring basis when an indication of impairment is identified and the asset's fair value is determined to be less than its carrying value.